Hiroko Hayama Dodge, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 41 | 2024 | 8038 | 2.150 |
Why?
|
| Cognition | 19 | 2024 | 6770 | 1.830 |
Why?
|
| Dementia | 25 | 2024 | 2518 | 1.790 |
Why?
|
| Aging | 28 | 2023 | 8664 | 1.630 |
Why?
|
| Cognition Disorders | 26 | 2018 | 4043 | 1.560 |
Why?
|
| Neuropsychological Tests | 39 | 2023 | 6994 | 1.450 |
Why?
|
| Dementia, Vascular | 2 | 2023 | 129 | 1.420 |
Why?
|
| Aged, 80 and over | 84 | 2023 | 57776 | 0.950 |
Why?
|
| Japan | 11 | 2020 | 1360 | 0.930 |
Why?
|
| Memory, Short-Term | 3 | 2020 | 977 | 0.920 |
Why?
|
| Activities of Daily Living | 17 | 2022 | 2419 | 0.920 |
Why?
|
| Mental Status Schedule | 9 | 2016 | 321 | 0.860 |
Why?
|
| Social Isolation | 3 | 2023 | 365 | 0.810 |
Why?
|
| Cerebrovascular Disorders | 4 | 2022 | 1504 | 0.790 |
Why?
|
| Executive Function | 6 | 2024 | 1364 | 0.690 |
Why?
|
| Lewy Body Disease | 1 | 2020 | 229 | 0.630 |
Why?
|
| Cohort Effect | 1 | 2016 | 39 | 0.580 |
Why?
|
| Personality | 1 | 2020 | 552 | 0.570 |
Why?
|
| Pennsylvania | 15 | 2023 | 613 | 0.560 |
Why?
|
| Aged | 87 | 2024 | 163288 | 0.550 |
Why?
|
| Oregon | 7 | 2021 | 140 | 0.550 |
Why?
|
| Disease Progression | 16 | 2024 | 13286 | 0.540 |
Why?
|
| Waist Circumference | 1 | 2020 | 917 | 0.540 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 2020 | 1344 | 0.530 |
Why?
|
| Mood Disorders | 1 | 2021 | 1106 | 0.510 |
Why?
|
| Monitoring, Ambulatory | 2 | 2015 | 355 | 0.490 |
Why?
|
| Microcomputers | 1 | 2014 | 147 | 0.490 |
Why?
|
| Independent Living | 6 | 2022 | 568 | 0.480 |
Why?
|
| Attitude to Computers | 1 | 2014 | 202 | 0.470 |
Why?
|
| Social Behavior | 3 | 2015 | 1127 | 0.440 |
Why?
|
| Research Subjects | 1 | 2014 | 239 | 0.430 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2014 | 271 | 0.430 |
Why?
|
| Computers | 4 | 2017 | 612 | 0.420 |
Why?
|
| Brain | 18 | 2023 | 26388 | 0.420 |
Why?
|
| Cognitive Dissonance | 1 | 2011 | 13 | 0.410 |
Why?
|
| Interview, Psychological | 1 | 2015 | 812 | 0.400 |
Why?
|
| Male | 92 | 2023 | 350115 | 0.390 |
Why?
|
| Walking | 3 | 2014 | 1180 | 0.380 |
Why?
|
| Longitudinal Studies | 23 | 2021 | 13991 | 0.370 |
Why?
|
| Geriatric Assessment | 13 | 2019 | 1372 | 0.370 |
Why?
|
| Memory | 4 | 2017 | 2174 | 0.360 |
Why?
|
| Speech | 1 | 2015 | 541 | 0.360 |
Why?
|
| Interpersonal Relations | 3 | 2014 | 1425 | 0.350 |
Why?
|
| Terminally Ill | 1 | 2012 | 238 | 0.350 |
Why?
|
| Female | 90 | 2021 | 380193 | 0.350 |
Why?
|
| Gait | 2 | 2012 | 793 | 0.350 |
Why?
|
| Neurofibrillary Tangles | 5 | 2023 | 439 | 0.350 |
Why?
|
| Humans | 121 | 2024 | 744366 | 0.340 |
Why?
|
| Attention | 1 | 2020 | 2397 | 0.340 |
Why?
|
| Cross-Cultural Comparison | 2 | 2010 | 651 | 0.320 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 638 | 0.320 |
Why?
|
| Risk Reduction Behavior | 4 | 2021 | 1125 | 0.320 |
Why?
|
| Seizures | 1 | 2020 | 2859 | 0.300 |
Why?
|
| Accidental Falls | 4 | 2020 | 1062 | 0.300 |
Why?
|
| Micronutrients | 1 | 2010 | 375 | 0.300 |
Why?
|
| Leisure Activities | 1 | 2008 | 311 | 0.290 |
Why?
|
| Telemedicine | 2 | 2021 | 2872 | 0.280 |
Why?
|
| Educational Status | 6 | 2023 | 2540 | 0.280 |
Why?
|
| Communication | 1 | 2020 | 3750 | 0.280 |
Why?
|
| Social Support | 3 | 2013 | 2118 | 0.270 |
Why?
|
| Psychomotor Performance | 5 | 2020 | 1901 | 0.260 |
Why?
|
| Self Disclosure | 1 | 2006 | 251 | 0.250 |
Why?
|
| Triglycerides | 1 | 2013 | 2453 | 0.250 |
Why?
|
| Disabled Persons | 3 | 2005 | 1212 | 0.250 |
Why?
|
| Logistic Models | 9 | 2019 | 13409 | 0.240 |
Why?
|
| Physicians, Family | 1 | 2006 | 345 | 0.240 |
Why?
|
| Asia | 2 | 2023 | 609 | 0.230 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2020 | 719 | 0.230 |
Why?
|
| Cholesterol, LDL | 1 | 2013 | 2355 | 0.220 |
Why?
|
| Risk Factors | 22 | 2023 | 72296 | 0.220 |
Why?
|
| Databases, Factual | 6 | 2020 | 7730 | 0.220 |
Why?
|
| Models, Statistical | 1 | 2018 | 5101 | 0.220 |
Why?
|
| Patient Selection | 1 | 2014 | 4216 | 0.210 |
Why?
|
| Prospective Studies | 19 | 2020 | 53290 | 0.210 |
Why?
|
| Cerebrovascular Circulation | 3 | 2018 | 2732 | 0.210 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2013 | 957 | 0.200 |
Why?
|
| Amnesia | 1 | 2023 | 248 | 0.200 |
Why?
|
| Cohort Studies | 25 | 2020 | 40559 | 0.200 |
Why?
|
| Cerebral Cortex | 1 | 2018 | 5709 | 0.200 |
Why?
|
| Medical Records | 2 | 2006 | 1413 | 0.200 |
Why?
|
| Michigan | 1 | 2021 | 350 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 3922 | 0.190 |
Why?
|
| Plaque, Amyloid | 3 | 2023 | 729 | 0.180 |
Why?
|
| Follow-Up Studies | 13 | 2017 | 39052 | 0.180 |
Why?
|
| Oxylipins | 1 | 2020 | 49 | 0.180 |
Why?
|
| Writing | 1 | 2021 | 206 | 0.180 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7914 | 0.170 |
Why?
|
| Speech Recognition Software | 1 | 2020 | 72 | 0.170 |
Why?
|
| Data Collection | 5 | 2018 | 3339 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2022 | 35425 | 0.170 |
Why?
|
| Amyloid beta-Peptides | 4 | 2024 | 3587 | 0.170 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 14723 | 0.170 |
Why?
|
| Loneliness | 2 | 2023 | 185 | 0.160 |
Why?
|
| Sex Factors | 6 | 2020 | 10400 | 0.160 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2020 | 227 | 0.160 |
Why?
|
| Telephone | 1 | 2021 | 617 | 0.160 |
Why?
|
| Cerebrum | 1 | 2019 | 137 | 0.150 |
Why?
|
| Metric System | 1 | 2017 | 1 | 0.150 |
Why?
|
| Life Expectancy | 2 | 2005 | 1184 | 0.150 |
Why?
|
| Arteriolosclerosis | 1 | 2017 | 21 | 0.150 |
Why?
|
| Online Systems | 1 | 2017 | 184 | 0.140 |
Why?
|
| Home Care Services | 1 | 2022 | 606 | 0.140 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2017 | 138 | 0.140 |
Why?
|
| Behavior Therapy | 1 | 2021 | 865 | 0.130 |
Why?
|
| Videoconferencing | 1 | 2017 | 195 | 0.130 |
Why?
|
| Copper | 1 | 2018 | 366 | 0.130 |
Why?
|
| International Cooperation | 2 | 2017 | 1420 | 0.130 |
Why?
|
| Biomedical Research | 3 | 2020 | 3309 | 0.120 |
Why?
|
| Frail Elderly | 1 | 2019 | 693 | 0.120 |
Why?
|
| Arachidonic Acid | 1 | 2016 | 434 | 0.120 |
Why?
|
| Thioctic Acid | 1 | 2014 | 23 | 0.120 |
Why?
|
| Cerebral Ventricles | 4 | 2022 | 544 | 0.120 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 440 | 0.120 |
Why?
|
| Hippocampus | 4 | 2016 | 3675 | 0.120 |
Why?
|
| Apolipoproteins E | 2 | 2016 | 1438 | 0.110 |
Why?
|
| Chi-Square Distribution | 4 | 2013 | 3508 | 0.110 |
Why?
|
| Tauopathies | 1 | 2017 | 307 | 0.110 |
Why?
|
| Counseling | 1 | 2021 | 1523 | 0.110 |
Why?
|
| Age Factors | 9 | 2016 | 18373 | 0.110 |
Why?
|
| Internet | 2 | 2016 | 3056 | 0.110 |
Why?
|
| Social Identification | 1 | 2013 | 103 | 0.110 |
Why?
|
| Proportional Hazards Models | 5 | 2016 | 12356 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 8949 | 0.110 |
Why?
|
| Autopsy | 4 | 2017 | 1020 | 0.100 |
Why?
|
| Rural Population | 6 | 2006 | 2207 | 0.100 |
Why?
|
| Sample Size | 1 | 2015 | 845 | 0.100 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 551 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2017 | 431 | 0.100 |
Why?
|
| Incidence | 4 | 2019 | 20952 | 0.100 |
Why?
|
| Memory Disorders | 3 | 2017 | 1186 | 0.100 |
Why?
|
| Depression | 6 | 2019 | 7759 | 0.100 |
Why?
|
| Pilot Projects | 4 | 2014 | 8319 | 0.100 |
Why?
|
| Cross-Sectional Studies | 11 | 2020 | 25039 | 0.100 |
Why?
|
| Regression Analysis | 3 | 2018 | 6459 | 0.100 |
Why?
|
| Serial Learning | 1 | 2010 | 45 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2018 | 745 | 0.100 |
Why?
|
| Spin Labels | 3 | 2018 | 332 | 0.100 |
Why?
|
| Caregivers | 2 | 2017 | 2095 | 0.090 |
Why?
|
| gamma-Tocopherol | 1 | 2010 | 31 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2012 | 475 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2017 | 1005 | 0.090 |
Why?
|
| Depressive Disorder | 2 | 2019 | 3747 | 0.090 |
Why?
|
| Postural Balance | 2 | 2011 | 620 | 0.090 |
Why?
|
| Affect | 2 | 2017 | 1475 | 0.090 |
Why?
|
| alpha-Tocopherol | 1 | 2010 | 127 | 0.090 |
Why?
|
| ROC Curve | 3 | 2018 | 3528 | 0.090 |
Why?
|
| Health Services Research | 1 | 2017 | 1836 | 0.090 |
Why?
|
| Physical Endurance | 1 | 2011 | 370 | 0.080 |
Why?
|
| Epidemiologic Studies | 2 | 2003 | 676 | 0.080 |
Why?
|
| Organ Size | 4 | 2017 | 2251 | 0.080 |
Why?
|
| Self Efficacy | 1 | 2012 | 615 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2016 | 1775 | 0.080 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2010 | 231 | 0.080 |
Why?
|
| Internationality | 1 | 2013 | 1002 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2018 | 3203 | 0.080 |
Why?
|
| Parietal Lobe | 1 | 2012 | 838 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2017 | 2241 | 0.080 |
Why?
|
| Vitamin B 12 | 1 | 2010 | 527 | 0.070 |
Why?
|
| Middle Aged | 17 | 2023 | 213390 | 0.070 |
Why?
|
| Homocysteine | 1 | 2010 | 647 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2213 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 2575 | 0.070 |
Why?
|
| Self Report | 2 | 2017 | 3553 | 0.070 |
Why?
|
| Equipment Design | 1 | 2014 | 3582 | 0.070 |
Why?
|
| Odds Ratio | 4 | 2014 | 9849 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2017 | 6036 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 1739 | 0.070 |
Why?
|
| Demography | 2 | 2011 | 1655 | 0.070 |
Why?
|
| Potassium | 1 | 2010 | 1336 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2737 | 0.070 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 15535 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 2016 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2009 | 651 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2009 | 982 | 0.060 |
Why?
|
| Psychometrics | 3 | 2011 | 3003 | 0.060 |
Why?
|
| Research | 1 | 2013 | 1999 | 0.060 |
Why?
|
| Sodium | 1 | 2010 | 1622 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2018 | 77460 | 0.060 |
Why?
|
| Mental Recall | 1 | 2010 | 1206 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9688 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 1534 | 0.060 |
Why?
|
| Institutionalization | 1 | 2004 | 104 | 0.060 |
Why?
|
| Language | 2 | 2023 | 1471 | 0.060 |
Why?
|
| Folic Acid | 1 | 2010 | 1300 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 3154 | 0.060 |
Why?
|
| Nutritional Status | 1 | 2011 | 1609 | 0.060 |
Why?
|
| Diphenhydramine | 1 | 2003 | 63 | 0.060 |
Why?
|
| tau Proteins | 1 | 2012 | 1868 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2016 | 6194 | 0.050 |
Why?
|
| Prevalence | 4 | 2015 | 15221 | 0.050 |
Why?
|
| Socioeconomic Factors | 5 | 2008 | 7785 | 0.050 |
Why?
|
| Residence Characteristics | 3 | 2014 | 2050 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12721 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2003 | 165 | 0.050 |
Why?
|
| Health Status | 2 | 2006 | 4034 | 0.050 |
Why?
|
| Mass Screening | 4 | 2020 | 5253 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8385 | 0.050 |
Why?
|
| Consensus | 2 | 2021 | 2960 | 0.050 |
Why?
|
| Comorbidity | 3 | 2011 | 10388 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 19905 | 0.050 |
Why?
|
| Europe | 2 | 2020 | 3338 | 0.050 |
Why?
|
| United States | 9 | 2023 | 69872 | 0.050 |
Why?
|
| Computational Biology | 2 | 2024 | 3519 | 0.050 |
Why?
|
| Antioxidants | 1 | 2009 | 1659 | 0.050 |
Why?
|
| Prognosis | 3 | 2018 | 29060 | 0.050 |
Why?
|
| Confidence Intervals | 4 | 2011 | 2971 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2019 | 23336 | 0.050 |
Why?
|
| Tape Recording | 1 | 2020 | 76 | 0.050 |
Why?
|
| Gambling | 1 | 2004 | 250 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2008 | 1161 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 304 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2012 | 5096 | 0.040 |
Why?
|
| Trail Making Test | 1 | 2020 | 57 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 194 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 8479 | 0.040 |
Why?
|
| Music Therapy | 1 | 2020 | 102 | 0.040 |
Why?
|
| Rural Health Services | 1 | 2003 | 379 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10637 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2016 | 1184 | 0.040 |
Why?
|
| Aquatic Organisms | 1 | 2019 | 48 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2022 | 652 | 0.040 |
Why?
|
| Reference Values | 1 | 2006 | 4982 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2022 | 607 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2006 | 2453 | 0.040 |
Why?
|
| Time Factors | 4 | 2019 | 40075 | 0.040 |
Why?
|
| Linear Models | 3 | 2016 | 5953 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2017 | 2887 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2004 | 1532 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6234 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2004 | 462 | 0.040 |
Why?
|
| Anxiety | 1 | 2012 | 4293 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2002 | 604 | 0.040 |
Why?
|
| Normal Distribution | 1 | 2018 | 280 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 242 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5749 | 0.040 |
Why?
|
| Hypotension | 1 | 2003 | 884 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 9955 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2018 | 2305 | 0.040 |
Why?
|
| India | 4 | 2004 | 2197 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2003 | 1183 | 0.040 |
Why?
|
| Nursing Homes | 1 | 2004 | 1036 | 0.040 |
Why?
|
| North America | 1 | 2020 | 1249 | 0.030 |
Why?
|
| Exercise | 2 | 2020 | 5615 | 0.030 |
Why?
|
| Disclosure | 1 | 2021 | 736 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 940 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2003 | 1162 | 0.030 |
Why?
|
| Health Priorities | 1 | 2017 | 380 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2014 | 35 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2003 | 1004 | 0.030 |
Why?
|
| Brain Infarction | 1 | 2016 | 299 | 0.030 |
Why?
|
| Sampling Studies | 2 | 2006 | 623 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 12746 | 0.030 |
Why?
|
| Lewy Bodies | 1 | 2013 | 137 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2019 | 12025 | 0.030 |
Why?
|
| Motor Activity | 2 | 2014 | 2715 | 0.030 |
Why?
|
| Australia | 1 | 2015 | 1167 | 0.030 |
Why?
|
| Predictive Value of Tests | 4 | 2011 | 15078 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2010 | 21748 | 0.030 |
Why?
|
| Apolipoprotein E3 | 1 | 2011 | 97 | 0.030 |
Why?
|
| Motivation | 1 | 2021 | 1971 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6366 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2017 | 2290 | 0.020 |
Why?
|
| Developing Countries | 1 | 2002 | 2815 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2012 | 535 | 0.020 |
Why?
|
| Medicaid | 1 | 2022 | 2737 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2016 | 1406 | 0.020 |
Why?
|
| Research Design | 2 | 2021 | 5984 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 214052 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2016 | 1359 | 0.020 |
Why?
|
| Atrophy | 1 | 2013 | 1584 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2010 | 468 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2006 | 4639 | 0.020 |
Why?
|
| Visual Perception | 1 | 2017 | 1420 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2016 | 1670 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2003 | 8551 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5077 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2002 | 9145 | 0.020 |
Why?
|
| Registries | 1 | 2003 | 8091 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2011 | 1000 | 0.020 |
Why?
|
| Algorithms | 2 | 2018 | 13882 | 0.020 |
Why?
|
| Mental Health | 1 | 2019 | 3010 | 0.020 |
Why?
|
| Apolipoprotein E4 | 1 | 2009 | 668 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 3326 | 0.020 |
Why?
|
| Medicare | 1 | 2022 | 6566 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12961 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 2775 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2004 | 505 | 0.010 |
Why?
|
| Vitamins | 1 | 2011 | 1623 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2003 | 374 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 1019 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6171 | 0.010 |
Why?
|
| Sick Role | 1 | 2002 | 237 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12244 | 0.010 |
Why?
|
| Stroke | 1 | 2004 | 9981 | 0.010 |
Why?
|
| Education | 1 | 2004 | 543 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16367 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2003 | 977 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2011 | 2624 | 0.010 |
Why?
|
| Automation | 1 | 2002 | 584 | 0.010 |
Why?
|
| Quality Control | 1 | 2002 | 841 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.010 |
Why?
|
| Social Environment | 1 | 2004 | 1022 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 2297 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3270 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 2373 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2004 | 2052 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 1637 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 2838 | 0.010 |
Why?
|
| Diet | 1 | 2011 | 7937 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2003 | 2616 | 0.010 |
Why?
|
| HIV Infections | 1 | 2017 | 16715 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 12788 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10252 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 168768 | 0.000 |
Why?
|
| Quality of Life | 1 | 2004 | 12802 | 0.000 |
Why?
|